ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Report Calls For Reinvigorated Cancer Program With Increased Funding, Greater Collaboration.

May 9, 2008

Obituary: Joseph Burchenal, 93, A Leader In Cancer Drug Development at MSKCC.

March 17, 2006

In Brief: Illinois Comprehensive Center Core Grant Approved, Probably Will Be Funded in FY 79

September 29, 1978

NCI, NIH Hoping 12 Percent Budget Cut Will Not Be Applied To Them

October 2, 1981

Breast Cancer Risk Increases With Repeated CT Imaging

December 28, 2012

Tobacco Council Grants Total 3,348

July 15, 1988